were performed with a Knick pH-meter (Knick, Berlin, Germany)
equipped with biotrode 238140 or tiptrode 238080 Hamilton
electrode (Hamilton, Bonaduz, Switzerland). Mass spectra were
recorded on Micromass QToF low resolution mass spectrometer
in ESI negative mode.
154.37 (C2G), 152.22 (C4G), 145.07 (C6C), 138.14 (C8G), 116.81
(C5G), 97.37 (C5C), 91.15 (C1¢C), 87.75 (C1¢G), 84.21 (d, JCP
=
8.7, C4¢G), 83.01 (d, JCP = 8.7, C4¢C), 75.50 (C2¢C), 74.22 (C2¢G),
70.97 (C3¢G), 68.98 (C3¢C), 66.05 (d, JCP = 5.0, C5¢G), 64.76 (d,
JCP = 3.7, C5¢C), 53.99 (CH3) ppm. MS (MALDI): m/z 725((M -
H)-, 69%) 515(33), 548(100), 699(51), 705(15).
Typical procedure of dinucleotide synthesis: Guanosine-5¢-
diphospho-5¢-cytidine (15) and guanosine-5¢-diphospho -5¢-N4-
methyl carbamate-cytidine (17). CMP(Bu3NH+)2 was prepared
from the CMP free acid (119.7 mg, 0.37 mmol) and Bu3N (176 mL,
2 eq) in 95% EtOH. GMP(Bu3NH+)2 was prepared from GMP
disodium salt by passing it through a column of activated Dowex
50WX-8 200 mesh, H+ form. The column eluate was collected
in an ice-cooled flask containing Bu3N (2 eq) and EtOH. The
resulting solution was freeze-dried to yield GMP(Bu3NH+)2. Bis-
tributylammonium CMP and CDI (348 mg, 2.15 mmol, 5.8
eq) were stirred in dry DMF under argon atmosphere at room
temperature for 2 h. Dry MeOH (140 mL, 3.45 mmol, 9.3 eq) was
added. After 20 min GMP(Bu3NH+)2 (311 mg, 0.42 mmol) in dry
DMF (6 mL) was added. The resulting solution was stirred at room
temperature for 24 h. Then DMF was evaporated and a viscous
oil was obtained. The resulting oil was separated on Sephadex
DEAE-A25, eluting the product with a buffer gradient of 0–0.3 M
NH4HCO3 (total volume 1000 mL). The product was obtained
in ca. 10% yield (26 mg) after LC separation. N4-Me-carbamate-
Gp2C, 17, was obtained in ca. 54% yield (152 mg). Final separation
of 15 was achieved by applying isocratic elution of TEAA–MeOH
94 : 6 in 30 min (5 mL min-1): tR 8.07 min. Final separation of 17
was achieved by applying isocratic elution of TEAA–MeOH 93 : 7
in 20 min (5 mL min-1): tR 16.73 min. Purity data obtained on
an analytical column for 15 and 17: tR 1.60 min; 3.73 min (99%
and 98% purity, respectively) using solvent system I (99 : 1 to 97 : 3
ammonium acetate–MeOH over 23 min, 1 mL min-1); tR 2.43 min;
5.72 min (93% and 99% purity respectively) using solvent system
II (99 : 1 to 97 : 3 of 0.01M KH2PO4 (pH=4.6)–MeOH over 23 min,
1 mL min-1).
1H NMR for 15 (600 MHz, D2O) d: 8.01 (s, 1H, H-8), 7.72
(d, J = 7.6, 1H, H-6), 5.88 (d, J = 7.6, 1H, H-5), 5.84 (d, J =
6.0, 1H, H-1¢G), 5.82 (d, J = 4.0, 1H, H-1¢C), 4.78 (dd, J = 6.0,
5.3,1H, H-2¢G), 4.46 (dd, J = 5.3, 3.3, 1H, H-3¢G), 4.31 (m, 1H,
H-4¢G), 4.24 (m, 3H, H-5¢G), 4.23 (m, 3H, H-5¢C), 4.22 (m, 3H,
H-3¢C), 4.18 (m, 3H, H-4¢C), 4.16 (m, 3H, H-2¢C), 4.15 (m, 3H,
H-5¢¢G), 4.12 (m, 1H, H-5¢¢C) ppm. 31P NMR (243 MHz, D2O) d:
-10.72 (s, Pa) ppm. 13C NMR (151 MHz, D2O) d :165.27 (C4C),
158.24 (C6G), 156.81 (C2C), 153.24 (C2G), 151.13 (C4G), 140.27
(C6C), 137.00 (C8G), 115.68 (C5G), 95.55 (C5C), 88.81 (C1¢C),
86.40 (C1¢G), 83.21 (d, JCP = 9.0, C4¢G), 81.74 (d, JCP = 9.0, C4¢C),
73.99 (C2¢C), 72.87 (C2¢G), 69.88 (C3¢G), 68.31 (C3¢C), 64.83 (d,
JCP = 4.0, C5¢G), 63.84 (d, JCP = 4.0, C5¢C) ppm. MS (MALDI):
m/z 667 ((M - H)-, 100%).
Guanosine-5¢-triphospho-5¢-cytidine (16). CMP(Bu3NH+ )2
was prepared from the CMP free acid (139 mg, 0.43 mmol) and
Bu3N (205 mL, 2 eq) in EtOH. GDP(Bu3NH+)2 was prepared
from GDP disodium salt (199.8 mg, 0.41 mmol) by passing it
through a column of activated Dowex 50WX-8 200 mesh, H+ form.
The column eluate was collected in an ice-cooled flask containing
Bu3N (2 eq) and EtOH. The resulting solution was freeze-dried
to yield GDP(Bu3NH+)2. Bis-tributylammonium CMP and CDI
(350.5 mg, 2.16 mmol, 5 eq) were stirred in dry DMF under argon
atmosphere at room temperature for 3.5 h. Dry MeOH (140 mL,
3.44 mmol, 8 eq) was added. After 5 min GDP(Bu3NH+)2 in dry
DMF (4 mL) was added. The resulting solution was stirred at room
temperature overnight. Then DMF was evaporated and a viscous
oil was obtained. The resulting oil was separated on Sephadex
DEAE-A25, eluting the product with a buffer gradient of 0–0.5 M
NH4HCO3 (total volume 1000 mL). The product was obtained in
ca. 3% yield (12 mg). Final purification of Gp3C was achieved by
HPLC isocratic elution with MeOH–0.1 M TEAA (pH = 7.5) 5 : 95
over 30 min, 5 mL min-1. Purity data obtained on an analytical
column for 16: tR 1.81 min (90% purity) using solvent system I
(100% ammonium acetate over 23 min, 1 mL min-1); tR 1.87 min
(99% purity) using solvent system II (100% of 0.01 M KH2PO4
(pH 4.6) over 23 min, 1 mL min-1).
1H NMR (600 MHz, D2O) d: 8.07 (s, 1H, H-8), 7.80 (d, J =
7.8, 1H, H-6), 5.91 (d, J = 7.8, 1H, H-5), 5.87 (d, J = 3.5, 1H,
H-1¢C), 5.86 (d, J = 6.5, 1H, H-1¢G), 4.49 (dd, J = 5.0, 3.0, 1H, H-
3¢G), 4.31 (quint, 1H, H-4¢G), 4.25 (m, 6H, H-3¢C), 4.24 (m, 6H,
H-5¢C), 4.24 (m, 6H, H-5¢¢C), 4.21 (m, 6H, H-2¢C), 4.20 (m, 6H,
H-5¢G), 4.20 (m, 6H, H-5¢¢G), 4.18 (m, 6H, H-4¢C) ppm. 31P NMR
(243 MHz, D2O) d: -10.78 (d, J = 18.7, Pa), -10.90 (d, J = 19.7,
Pa), -22.42 (t, J = 19.1, Pb) ppm. 13C NMR (151 MHz, D2O) d :
166.46 (C4C), 159.42 (C6G), 158.00 (C2C), 154.52 (C2G), 152.37
(C4G), 141.51 (C6C), 138.11 (C8G), 116.78 (C5G), 96.79 (C5C),
89.91 (C1¢C), 87.22 (C1¢G), 84.58 (d, JCP = 8.7, C4¢G), 82.82 (d,
JCP = 9.3, C4¢C), 75.08 (C2¢C), 74.50 (C2¢G), 71.32 (C3¢G), 69.33
(C3¢C), 65.95 (d, JCP = 4.5, C5¢G), 64.87 (d, JCP = 4.5, C5¢C) ppm.
MS (MALDI): m/z 747((M - H)-, 100%) 515(15), 548(48).
NMR Experiments
Preparation of NMR samples. dinucleotide sodium salts were
disssolved in 99.9% D2O and pD was adjusted to a physiological
pH (pD = 7.4
0.2, pD = pH + 0.4). NMR spectra were
measured at 600 MHz, 300 K 0.5, using glycerol as an internal
reference. The sample concentration was kept low enough to
avoid intermolecular base stacking yet, high enough to enable
the detection of clear and sharp NMR signals.42,51 Therefore, the
concentration of dinucleotides in the NMR samples was 7.5 mM.
1H NMR for 17 (600 MHz, D2O) d: 8.08 (d, J = 7.6, 1H, H-
6), 7.95 (s, 1H, H-8), 6.92 (d, J = 7.6, 1H, H-5), 5.97 (d, J =
5.7, 1H, H-1¢G), 5.82 (d, J = 2.7, 1H, H-1¢C), 4.71 (dd, J = 5.7,
5.3,1H, H-2¢G), 4.45 (dd, J = 5.3, 3.7, 1H, H-3¢G), 4.34 (m, 1H,
H-5¢C), 4.29 (m, 2H, H-4¢G), 4.28 (m, 2H, H-5¢G), 4.24 (m, 3H,
H-3¢C), 4.24 (m, 3H, H-4¢C), 4.21 (m, 3H, H-2¢C), 4.18 (m, 2H,
H-5¢¢G), 4.17 (m, 2H, H-5¢¢C), 3.77 (s, 3H, OMe) ppm. 31P NMR
(243 MHz, D2O) d: -10.48 (s, Pa) ppm. 13C NMR (151 MHz, D2O)
d : 163.53 (C4C), 159.29 (C6G), 157.24 (C2C), 154.80 (COOMe)
Analysis of 1H, 13C, 31P-NMR data for compounds 1–17.
The ribose conformation of the dinucleotides was analyzed in
terms of a dynamic equilibrium between two favored puckered
conformations North (N) conformer and South (S) conformer N
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 4637–4652 | 4649
©